Vol 73, No 1 (2022)
Original paper
Published online: 2021-11-04
Differences in sex hormone levels in the menstrual cycle due to tobacco smoking — myth or reality?
1
, 23, 4, 1, 5, 6, 1, 6, 7, 8
, 23, 4, 1, 5, 6, 1, 6, 7, 8
Abstract
Introduction: Tobacco smoke contains, among others, polycyclic aromatic hydrocarbons (PAHs), heterocyclic analogues, aromatic amines, N-nitrosamines, volatile hydrocarbons, aldehydes, phenols, miscellaneous organic compounds, metals, and inorganic compounds. Tobacco smoking can harm women’s reproductive system and may reduce fertility. The objective of the study was to explore the effect of tobacco smoke on the menstrual cycle due to smoking and second-hand smoke-exposure.
Material and methods: The study was performed on 153 women of reproductive age, who received care at the Gynaecological-Obstetric Clinical Hospital of the Poznan University of Medical Sciences. They were divided into three treatment groups: non-smokers, secondhand smokers, and smokers. Comprehensive assessment of all hormone levels: follicle-stimulating hormone (FSH), luteinizing hormone (LH), 17β-oestradiol (E2), and progesterone (P), in the various phases of the menstrual cycle and with concomitant determinations of serum cotinine concentrations was performed. The menstrual cycle was observed with ultrasonography.
Results: Cigarette smoking may be an important factor in disrupting reproduction: 1. The increase in the oestradiol E2 level was accompanied by significantly lowered serum cotinine concentrations in tobacco smokers; 2. In smoking patients, the serum level of LH significantly increased on the first days of the menstrual cycle; 3. The higher levels of P (in the 14th and 21st days) were assumed to be the result of a longer menstrual cycle.
Conclusions: Active and passive smoking may be an important contributor to reproductive health issues and deserves greater focus in health education programs directed towards women of reproductive age.
Keywords: menstrual cycletobacco smokingsex hormonesfertility
References
- Talhout R, Schulz T, Florek E, et al. Hazardous compounds in tobacco smoke. Int J Environ Res Public Health. 2011; 8(2): 613–628.
- Borgerding M, Klus H. Analysis of complex mixtures--cigarette smoke. Exp Toxicol Pathol. 2005; 57 Suppl 1: 43–73.
- Fowles J, Dybing E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob Control. 2003; 12(4): 424–430.
- Benowitz NL, Hukkanen J, Jacob P. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol. 2009(192): 29–60.
- Bergen AW, Caporaso N. Cigarette smoking. J Natl Cancer Inst. 1999; 91(16): 1365–1375.
- Szyfter K, Napierala M, Florek E, et al. Molecular and health effects in the upper respiratory tract associated with tobacco smoking other than cigarettes. Int J Cancer. 2019; 144(11): 2635–2643.
- Thun M, Peto R, Boreham J, et al. Stages of the cigarette epidemic on entering its second century. Tob Control. 2012; 21(2): 96–101.
- Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol. 2012; 13(11): 1141–1151.
- Lange S, Probst C, Rehm J, et al. National, regional, and global prevalence of smoking during pregnancy in the general population: a systematic review and meta-analysis. Lancet Glob Health. 2018; 6(7): e769–e776.
- Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org, Practice Committee of the American Society for Reproductive Medicine. Smoking and infertility: a committee opinion. Fertil Steril. 2018; 110(4): 611–618.
- Allen AM, Oncken C, Hatsukami D. Women and Smoking: The Effect of Gender on the Epidemiology, Health Effects, and Cessation of Smoking. Curr Addict Rep. 2014; 1(1): 53–60.
- Mackay J, Amos A. Women and tobacco. Respirology. 2003; 8(2): 123–130.
- Vardavas CI, Nikitara K. COVID-19 and smoking: A systematic review of the evidence. Tob Induc Dis. 2020; 18: 20.
- Cai H. Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir Med. 2020; 8(4): e20.
- Czekaj P, Wiaderkiewicz A, Florek E, et al. Tobacco smoke-dependent changes in cytochrome P450 1A1, 1A2, and 2E1 protein expressions in fetuses, newborns, pregnant rats, and human placenta. Arch Toxicol. 2005; 79(1): 13–24.
- Sadeu JC, Foster WG. The cigarette smoke constituent benzo[a]pyrene disrupts metabolic enzyme, and apoptosis pathway member gene expression in ovarian follicles. Reprod Toxicol. 2013; 40: 52–59.
- Mello NK, Mendelson JH, Palmieri SL. Cigarette smoking by women: interactions with alcohol use. Psychopharmacology (Berl). 1987; 93(1): 8–15.
- Steinberg JL, Cherek DR. Menstrual cycle and cigarette smoking behavior. Addict Behav. 1989; 14(2): 173–179.
- Craig D, Parrott A, Coomber JA. Smoking cessation in women: effects of the menstrual cycle. Int J Addict. 1992; 27(6): 697–706.
- Marks JL, Hair CS, Klock SC, et al. Effects of menstrual phase on intake of nicotine, caffeine, and alcohol and nonprescribed drugs in women with late luteal phase dysphoric disorder. J Subst Abuse. 1994; 6(2): 235–243.
- Sakai H, Ohashi K. Association of menstrual phase with smoking behavior, mood and menstrual phase-associated symptoms among young Japanese women smokers. BMC Womens Health. 2013; 13: 10.
- Freour T, Dessolle L, Jean M, et al. Predictive value of ovarian reserve markers in smoking and non-smoking women undergoing IVF. Reprod Biomed Online. 2010; 20(6): 857–860.
- Freour T, Masson D, Dessolle L, et al. Ovarian reserve and in vitro fertilization cycles outcome according to women smoking status and stimulation regimen. Arch Gynecol Obstet. 2012; 285(4): 1177–1182.
- Plante BJ, Cooper GS, Baird DD, et al. The impact of smoking on antimüllerian hormone levels in women aged 38 to 50 years. Menopause. 2010; 17(3): 571–576.
- Sowers MR, McConnell D, Yosef M, et al. Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period. Ann N Y Acad Sci. 2010; 1204: 95–103.
- Lammert S, Harrison K, Tosun N, et al. Menstrual Cycle in Women Who Co-use Marijuana and Tobacco. J Addict Med. 2018; 12(3): 207–211.
- Snively TA, Ahijevych KL, Bernhard LA, et al. Smoking behavior, dysphoric states and the menstrual cycle: results from single smoking sessions and the natural environment. Psychoneuroendocrinology. 2000; 25(7): 677–691.
- Allen SS, Hatsukami D, Christianson D, et al. Symptomatology and energy intake during the menstrual cycle in smoking women. J Subst Abuse. 1996; 8(3): 303–319.
- Jensvold MF, Hamilton JA, Halbreich U. Future research directions. Methodological considerations for advancing gender-sensitive pharmacology. In: Jensvold MF. ed. Psychopharmacology and women: Sex, gender, and hormones. American Psychiatric Press, Washington 1996: 415.
- Heatherton T, Kozlowski L, Frecker R, et al. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991; 86(9): 1119–1127.
- Napierala M, Merritt TA, Miechowicz I, et al. The effect of maternal tobacco smoking and second-hand tobacco smoke exposure on human milk oxidant-antioxidant status. Environ Res. 2019; 170: 110–121.
- Windham GC, Mitchell P, Anderson M, et al. Cigarette smoking and effects on hormone function in premenopausal women. Environ Health Perspect. 2005; 113(10): 1285–1290.
- Cramer DW, Barbieri RL, Xu H, et al. Determinants of basal follicle-stimulating hormone levels in premenopausal women. J Clin Endocrinol Metab. 1994; 79(4): 1105–1109.
- De Souza MJ, Miller BE, Loucks AB, et al. High frequency of luteal phase deficiency and anovulation in recreational women runners: blunted elevation in follicle-stimulating hormone observed during luteal-follicular transition. J Clin Endocrinol Metab. 1998; 83(12): 4220–4232.
- Fukuda M, Fukuda K, Andersen CY, et al. Characteristics of human ovulation in natural cycles correlated with age and achievement of pregnancy. Hum Reprod. 2001; 16(12): 2501–2507.
- Tulppala M, Björses UM, Stenman UH, et al. Luteal phase defect in habitual abortion: progesterone in saliva. Fertil Steril. 1991; 56(1): 41–44.
- Wuttke W, Pitzel L, Seidlová-Wuttke D, et al. LH pulses and the corpus luteum: the luteal phase deficiency LPD). Vitam Horm. 2001; 63: 131–158.
- Mitra A, Chakraborty B, Mukhopadhay D, et al. Effect of smoking on semen quality, FSH, testosterone level, and CAG repeat length in androgen receptor gene of infertile men in an Indian city. Syst Biol Reprod Med. 2012; 58(5): 255–262.
- Jandíková H, Dušková M, Stárka L. The influence of smoking and cessation on the human reproductive hormonal balance. Physiol Res. 2017; 66(Suppl 3): S323–S331.
- Tweed JO, Hsia SH, Lutfy K, et al. The endocrine effects of nicotine and cigarette smoke. Trends Endocrinol Metab. 2012; 23(7): 334–342.
- Dušková M, Simůnková K, Hill M, et al. Chronic cigarette smoking alters circulating sex hormones and neuroactive steroids in premenopausal women. Physiol Res. 2012; 61(1): 97–111.
- Neves Cruz J, Santana de Oliveira M, Gomes Silva S, et al. Insight into the Interaction Mechanism of Nicotine, NNK, and NNN with Cytochrome P450 2A13 Based on Molecular Dynamics Simulation. J Chem Inf Model. 2020; 60(2): 766–776.
- Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clin Pharmacokinet. 1999; 36(6): 425–438.
- Siegfried JM. Early changes in pulmonary gene expression following tobacco exposure shed light on the role of estrogen metabolism in lung carcinogenesis. Cancer Prev Res (Phila). 2010; 3(6): 692–695.
- Benowitz NL, Jacob P. Trans-3'-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smoking. Br J Clin Pharmacol. 2001; 51(1): 53–59.
- Spink D, Eugster HP, Lincoln D, et al. 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1A1: A comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. Arch Biochem Biophys. 1992; 293(2): 342–348.
- Tankó LB, Christiansen C. An update on the antiestrogenic effect of smoking: a literature review with implications for researchers and practitioners. Menopause. 2004; 11(1): 104–109.
- Mueck AO, Seeger H, Mueck AO, et al. Smoking, estradiol metabolism and hormone replacement therapy. Arzneimittelforschung. 2003; 53(1): 1–11.
- Spangler JG. Smoking and hormone-related disorders. Prim Care. 1999; 26(3): 499–511.
- Kapoor D, Jones TH. Smoking and hormones in health and endocrine disorders. Eur J Endocrinol. 2005; 152(4): 491–499.
- Soldin OP, Makambi KH, Soldin SJ, et al. Steroid hormone levels associated with passive and active smoking. Steroids. 2011; 76(7): 653–659.
- Whitcomb BW, Bodach SD, Mumford SL, et al. Ovarian function and cigarette smoking. Paediatr Perinat Epidemiol. 2010; 24(5): 433–440.
- Caserta D, Bordi G, Di Segni N, et al. The influence of cigarette smoking on a population of infertile men and women. Arch Gynecol Obstet. 2013; 287(4): 813–818.
- Miceli F, Minici F, Tropea A, et al. Effects of nicotine on human luteal cells in vitro: a possible role on reproductive outcome for smoking women. Biol Reprod. 2005; 72(3): 628–632.
- Zenzes MT, Reed TE, Casper RF. Effects of cigarette smoking and age on the maturation of human oocytes. Hum Reprod. 1997; 12(8): 1736–1741.
- Issat T, Nowicka MA, Oleksik TP, et al. Serum progesterone concentrations on the day of oocyte retrieval above 9.23 ng/ml may predict ovarian hyperstimulation syndrome risk in in vitro fertilized patients. J Physiol Pharmacol. 2019; 70(5).
- Hawkins SM, Matzuk MM. The menstrual cycle: basic biology. Ann N Y Acad Sci. 2008; 1135: 10–18.
- Shea A, Vitzthum V. The extent and causes of natural variation in menstrual cycles: Integrating empirically-based models of ovarian cycling into research on women’s health. Drug Discov Today: Disease Models. 2020; 32: 41–49.
- Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev. 1996; 18(2): 188–204.
- Benowitz NL, Jacob P. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther. 1994; 56(5): 483–493.
- Benowitz NL, Jacob P, Benowitz NL, et al. Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking. Br J Clin Pharmacol. 1997; 43(3): 259–267.
